Posts

Full-spectrum cell-free RAN for 6G systems: system desi...

A long-form review, titled ” Full-spectrum Cell-free RAN for 6G Systems: System ...

FSU researchers develop new test for detecting cancer b...

When doctors are examining suspected cancer cases, they turn to biomarker tests ...

Gut bacteria use super-polymers to dodge antibiotics

The discovery shows why it can be so difficult to tackle drug-resistant bacteria...

Study points to new approach to treat chronic transplan...

University of Pittsburgh researchers have identified a type of immune cell that ...

Putting hydrogen on solid ground: Simulations with a ma...

Hydrogen, the most abundant element in the universe, is found everywhere from th...

Cheaper method for making woven displays and smart fabr...

Researchers have developed next-generation smart textiles – incorporating LEDs, ...

New approach to developing efficient, high-precision 3D...

Modern-day technologies like optical computing, integrated photonics, and digita...

Researchers develop safety monitoring system for constr...

University of Houston computer scientists have developed a new system to keep co...

Want to make better materials? Read between the lines. ...

The orientations of these infinitesimally small separations between individual “...

Moderna and Merck’s Cancer Vaccine Shows Promising Data

Biotech firm Moderna has released comprehensive data from mid-stage research on ...

FDA Rejects Eli Lilly’s Bowel Disease Drug Citing Manuf...

Eli Lilly’s mirikizumab, an IL-23 inhibitor, has recently been rejected by the F...

Illumina partners with Henry Ford Health to analyze gen...

Illumina has entered into a joint agreement with Henry Ford Health to analyze th...

Noah Medical Raises $150 Million in Funding for Robotic...

Noah Medical, a Silicon Valley-based robotic lung surgery company, has raised $1...

Tubulis and Bristol Myers Squibb agree to develop ADCs ...

Bristol Myers Squibb will be solely responsible for the development, production ...

Targovax announces plans to rebrand as Circio

Circio will initially focus on developing new circRNA medicines for cancer, with...

Zucara Therapeutics receives FDA IND approval for ZT-01

The FDA IND approval allows Zucara to begin its Phase IIa ZONE trial of ZT-01 in...